PARTNERING & INVESTMENT

 

IsletOne Therapeutics is capitalizing on the fertile translational environment at the Karolinska Institute and the Karolinska University Hospital. The company's asset-centric business model enables low CapEx operations with a strong focus on advancing its well-protected groundbreaking clinical and pre-clinical pipeline, which centers on the treatment of systemic diseases with an underlying inflammatory and immunologic etiology, using intravenous delivery of cell therapeutics.

 

For queries relating to investment or partnering, please send an e-mail to: info@isletone.se

Copyright © All Rights Reserved

ADRESS

IsletOne AB
Hälsovägen 7,  SE-14157, Huddinge, Sweden

CONTACT US